site stats

Biolytx pharmaceuticals corp

WebBiolytx Pharmaceuticals is an example of what life science companies go through. Biolytx has developed a novel new drug to fight antibiotic-resistant bacteria. ... Scott Meacham is president and CEO of i2E Inc., a nonprofit corporation that mentors many of the state’s technology-based startup companies. i2E receives state appropriations from ... WebDec 15, 2015 · In 2005, Pereira founded the company Biolytx Pharmaceutical Corp., and she currently serves as Chief Scientific Officer for the company. In the last 10 years, antibiotic-resistant infections have ...

Biolytx Pharmaceuticals picks up $1.1 mill - i2E

WebWilliam A. Hagstrom. Mr. Hagstrom has served as a member of our Board of Directors since incorporation in 2005. He has served as the founder and CEO of Octave Bioscience, an early-stage diagnostics company focused on neurodegenerative diseases since 2014. WebBiolytx Pharmaceuticals is a pharmaceutical technology company developed by Dr. Anne Pereira and the University of Oklahoma Health Sciences Center. Still in the pre-clinical trial stage, the company's core technology is the development of a novel antibiotic peptide for use in treatment of serious hospital-acquired infections, including those ... fixtures and more https://illuminateyourlife.org

Management Team – Biolytx Pharmaceuticals Corp.

WebBiolytx Pharmaceuticals. Biolytx is an emerging drug development company confronting the crisis in antibiotic (AB) drug resistance through the advancement of a suite of … Dr. Pereira is the holder of 15 US patents and 4 foreign patents licensed to Biolytx. … The CSO of Biolytx characterized, sequenced, and cloned the peptide and … BP001. BP001 is an antibiotic and wound healing agent for infected eye wounds. … Pre-Clinical Stage. All of our drug candidates are in the pre-clinical stage … INVESTORS We completed a $1.5 million seed round of financing in 2015, led by … Biolytx Pharmaceuticals Targets Drug-Resistant Bacteria March 25 , 2015 – … Biolytx Pharmaceuticals Corporation 800 Research Parkway, Suite Oklahoma … William A Hagstrom Board Member and Co-Founder. Mr. Hagstrom has served as a … WebJul 29, 2024 · Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Cystic Fibrosis – Drugs In Development, 2024, provides an overview of the Cystic Fibrosis (Respiratory) pipeline landscape. Cystic fibrosis (CF) is an inherited disease that causes mucus to build up and clog some of the body’s organs, particularly the lungs … WebBiolytx has a portfolio of antimicrobial peptides based on the naturally occurring human CAP37 (Cationic Antimicrobial Peptide), which is one of the proteins secreted at wound … fixtures and power supply

Biolytx Pharmaceuticals Corp - Company Profile and News

Category:Biolytx Pharmaceuticals - Crunchbase Company Profile

Tags:Biolytx pharmaceuticals corp

Biolytx pharmaceuticals corp

OU Grad Dean targets drug-resistant bacteria - i2E

WebBiolytx Pharmaceuticals. Drug Stores & Pharmacies · Oklahoma, United States · <25 Employees . Founded in 2005 by H. Anne Pereira, Ph.D., and William A. Hagstrom, … WebMay 13, 2024 · Biofilm Pharma ; Biolytx Pharmaceuticals Corp ; Boehringer Ingelheim International GmbH ; Boston Pharmaceuticals Inc ; Breathe Easy Therapeutics Ltd ; …

Biolytx pharmaceuticals corp

Did you know?

WebFind company research, competitor information, contact details & financial data for Biolytx Pharmaceuticals Corp. of Oklahoma City, OK. Get the latest business insights from … WebJul 8, 2015 · Biolytx Pharmaceuticals has a novel new drug developed from a peptide (a small part of a protein) that is created by the human body. ... a nonprofit corporation that mentors many of the state’s technology-based startup companies. i2E receives state appropriations from the Oklahoma Center for the Advancement of Science and Technology.

WebOct 16, 2015 · Biolytx Pharmaceuticals General Information. Description. Developer of peptide-based antibiotics designed to treat serious pathogens with no current therapeutic options. The company's antibiotics include a suite of antimicrobial drug candidates for the treatment of serious pathogens including those resistant to current antibiotics, enabling ... WebThe Township of Fawn Creek is located in Montgomery County, Kansas, United States. The place is catalogued as Civil by the U.S. Board on Geographic Names and its elevation …

WebBiolytx Pharmaceuticals Corp. Jan 2016 - May 2024 3 years 5 months. Oklahoma City, Oklahoma Vice President and General Counsel Amicus Therapeutics ...

WebBIOLYTX PHARMACEUTICALS CORP. Details Filing Number: 2312083786 Name Type: Legal Name Status: OTC Suspension . A domestic or foreign corporation has not complied with OK tax requirements. Corp type: Foreign For Profit Business Corporation ...

WebFounded Date 2005. Founders H. Anne Pereira, William Hagstrom. Operating Status Active. Last Funding Type Seed. Company Type For Profit. Contact Email … canning supplies mason jar lidsWebAddress: 800 Research Pkwy Ste 334 Oklahoma City, OK, 73104-3600 United States canning supplies jar lifterWebBiolytx Pharmaceuticals Corp. is developing a peptide, BP001, derived from the human endogenous host defense protein CAP37, as a novel multi-target ophthalmic product for … canning supplies seattleWebNov 11, 2015 · Biolytx Pharmaceuticals picks up $1.1 mill By Iris Dorbian ... Biolytx is developing a promising drug designed to promote wound healing and kill antibiotic resistant bacteria. This latest financing round also included $200,000 from the i2E-managed SeedStep Angels group, as well as $250,000 from an Oklahoma venture capital fund and … canning supplies kitWebBIOLYTX PHARMACEUTICALS CORP VentureRadar profile. Find out more about BIOLYTX PHARMACEUTICALS CORP including the VentureRadar Innovation and … canning supplies nycWebA: Biolytx Pharmaceuticals Corp is located at: 800 Research Pkwy #334, Oklahoma City, OK 73104, USA, United States Q: What are the coordinates of the Biolytx Pharmaceuticals Corp? A: Latitude: 35.4755934, Longitude: -97.5037017 canning supplies onlineWebWilliam A. Hagstrom is an entrepreneur and businessperson who founded Biolytx Pharmaceuticals Corp., Crescendo Bioscience, Inc., Altheus Therapeutics, Inc. and Octave Bioscience, Inc. and who has been... fixtures and predictions for today